MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

349.46 +0.69 (+0.20%)
Streaming Delayed Price Updated: 3:09 PM EDT, Mar 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,128,778
Open 351.83
Bid (Size) 349.34 (80)
Ask (Size) 349.63 (40)
Prev. Close 348.77
Today's Range 348.13 - 351.83
52wk Range 261.43 - 391.29
Shares Outstanding 538,800,000
Dividend Yield 2.88%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks ↗
The Schwab U.S. Dividend Equity ETF is increasing its allocation to healthcare dividend stocks. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
Institutional Titans Bet Big on Amgen as Dividend Yield Hits 2.9% Benchmark
In a decisive show of confidence for the biotechnology sector, institutional heavyweights have significantly ramped up their positions in Amgen (NASDAQ: AMGN) throughout the first quarter of 2026.... 
Via MarketMinute
Topics ETFs Earnings

Performance

YTD
+6.7%
+6.7%
1 Month
-10.0%
-10.0%
3 Month
+6.0%
+6.0%
6 Month
+27.6%
+27.6%
1 Year
+12.2%
+12.2%

More News

Read More
News headline image
FDA Approves Protagonist’s ICOTYDE: The Oral Peptide Revolution Hits the Psoriasis Market
Via MarketMinute
News headline image
Anthropic Is Worth $380 Billion: This Little-Known ETF Could Let You Own a Piece Before It IPOs ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
AbbVie Shares Retreat to Multi-Month Lows Amid Competitive Headwinds and Technical Breakdown
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report ↗
Via Benzinga
News headline image
1 ETF That Could Turn $100 Per Month Into $67,380 ↗
Via The Motley Fool
Topics ETFs Economy World Trade
News headline image
2 Mega-Cap Stocks to Keep an Eye On and 1 Facing Headwinds
Via StockStory
Topics Energy
News headline image
Rapid Micro (RPID) Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
Better Weight Loss Stock: Novo Nordisk Vs. Amgen ↗
Via The Motley Fool
News headline image
IBRX Stock Extends Rally To Day 3: Founder Drops ‘Prelude’ To 2025 Earnings, Slams Bristol Myers, Amgen Cancer Playbook ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
2 Profitable Stocks with Solid Fundamentals and 1 Facing Headwinds
Via StockStory
News headline image
A Couple's Financial Manifesto, Revisited ↗
Via The Motley Fool
Topics Stocks
News headline image
The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026
Via Finterra
Topics Economy Intellectual Property
News headline image
Novo Nordisk Shares Tumble 15.1% After CagriSema Fails to Topple Eli Lilly in Head-to-Head Trial
Via MarketMinute
News headline image
Eli Lilly Surges as Novo Nordisk’s "CagriSema" Stumbles in High-Stakes Obesity Head-to-Head
Via MarketMinute
News headline image
Novo Nordisk Shares Plunge 13% as Next-Gen Weight Loss Drug CagriSema Fails to Topple Eli Lilly in Landmark Trial
Via MarketMinute
Topics Earnings
News headline image
1 Unpopular Stock That Deserves a Second Chance and 2 We Turn Down
Via StockStory
News headline image
1 Momentum Stock to Research Further and 2 We Avoid
Via StockStory
News headline image
The Trillion-Dollar Pharmaceutical Giant: Eli Lilly Makes History as Weight-Loss Revolution Drives Unprecedented Growth
Via MarketMinute
Topics Earnings Economy
News headline image
Gilead Sciences and the 2026 Biotech Resurgence: A Leader in the Great Rotation
Via MarketMinute
Topics Artificial Intelligence ETFs Government
News headline image
1 Large-Cap Stock Worth Your Attention and 2 We Avoid
Via StockStory
News headline image
The 5 Most Interesting Analyst Questions From Amgen’s Q4 Earnings Call
Via StockStory
Topics Earnings
News headline image
The Great GLP-1 Divergence: Eli Lilly Surges Toward Trillion-Dollar Dominance as Novo Nordisk Falters on U.S. Price Cuts
Via MarketMinute
Topics Earnings Economy

Frequently Asked Questions

Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 349.46
When was Amgen last traded?
The last trade of Amgen was at 03/30/26 03:09 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 188.29B
How many shares of Amgen are outstanding?
Amgen has 188B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story